{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:08:00Z","timestamp":1794571680298,"version":"4.9.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The global rate of major noncardiac surgical procedures is increasing annually, and of those patients presenting for surgery, increasing numbers are taking either an angiotensin-converting enzyme inhibitor (ACE-I) or an angiotensin receptor blocker (ARB). The current recommendations of whether to continue or withhold ACE-I and ARB in the perioperative period are conflicting. Previous meta-analyses have linked preoperative ACE-I\/ARB therapy to the increased incidence of postinduction hypotension; however, they have failed to correlate this with adverse patient outcomes. The aim of this meta-analysis was to determine whether continuation or withholding ACE-I or ARB therapy in the perioperative period is associated with mortality and major morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This meta-analysis was prospectively registered on PROSPERO (CRD42017055291). A comprehensive search of MEDLINE (PubMed), CINAHL (EBSCO host), ProQuest, Cochrane database, Scopus, and Web of Science was conducted on December 6, 2016. We included adult patients &gt;18 years of age on chronic ACE-I or ARB therapy who underwent noncardiac surgery in which ACE-I or ARB was either withheld or continued on the morning of surgery. Primary outcomes included all-cause mortality and major cardiac events (MACE). Secondary outcomes included the risk of congestive heart failure, acute kidney injury, stroke, intraoperative\/postoperative hypotension, and the length of hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      After abstract review, the full text of 25 studies was retrieved, of which 9 fulfilled the inclusion criteria: 5 were randomized control trials, and 4 were cohort studies. These studies included a total of 6022 patients on chronic ACE-I\/ARB therapy before noncardiac surgery. A total of 1816 patients withheld treatment the morning of surgery and 4206 continued their ACE-I\/ARB. Preoperative demographics were similar between the 2 groups. Withholding ACE-I\/ARB therapy was not associated with a difference in mortality (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.62\u20131.52;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0%) or MACE (OR, 1.12; 95% CI, 0.82\u20131.52;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0%). However, withholding therapy was associated with significantly less intraoperative hypotension (OR, 0.63; 95% CI, 0.47\u20130.85;\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 71%). No effect estimate could be pooled concerning length of hospital stay and congestive heart failure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>This meta-analysis did not demonstrate an association between perioperative administration of ACE-I\/ARB and mortality or MACE. It did, however, confirm the current observation that perioperative continuation of ACE-I\/ARBs is associated with an increased incidence of intraoperative hypotension. A large randomized control trial is necessary to determine the appropriate perioperative management of ACE-I and ARBs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000002837","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T06:55:33Z","timestamp":1517295333000},"page":"678-687","source":"Crossref","is-referenced-by-count":183,"title":["A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery"],"prefix":"10.1213","volume":"127","author":[{"given":"Caryl","family":"Hollmann","sequence":"first","affiliation":[{"name":"From the Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"From the Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Biccard","sequence":"additional","affiliation":[{"name":"From the Department of Anaesthesia and Perioperative Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230721","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(08)60878-8","article-title":"An estimation of the global volume of surgery: a modelling strategy based on available data.","volume":"372","author":"Weiser","year":"2008","journal-title":"Lancet"},{"key":"R2-20230721","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort.","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"key":"R3-20230721","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00000542-199408000-00006","article-title":"Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction.","volume":"81","author":"Coriat","year":"1994","journal-title":"Anesthesiology"},{"key":"R4-20230721","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00000539-200101000-00006","article-title":"Should the angiotensin II antagonists be discontinued before surgery?","volume":"92","author":"Bertrand","year":"2001","journal-title":"Anesth Analg"},{"key":"R5-20230721","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1213\/ANE.0000000000000302","article-title":"The long-term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery.","volume":"119","author":"Foucrier","year":"2014","journal-title":"Anesth Analg"},{"key":"R6-20230721","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-154-8-201104190-00003","article-title":"Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study.","volume":"154","author":"Devereaux","year":"2011","journal-title":"Ann Intern Med"},{"key":"R7-20230721","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.avsg.2012.12.001","article-title":"Impact of adding aspirin to beta-blocker and statin in high-risk patients undergoing major vascular surgery.","volume":"27","author":"Lau","year":"2013","journal-title":"Ann Vasc Surg"},{"key":"R8-20230721","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jacc.2014.07.944","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines.","volume":"64","author":"Fleisher","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R9-20230721","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cjca.2016.09.008","article-title":"Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery.","volume":"33","author":"Duceppe","year":"2017","journal-title":"Can J Cardiol"},{"key":"R10-20230721","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","article-title":"2014 ESC\/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"R11-20230721","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jhm.323","article-title":"Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period.","volume":"3","author":"Rosenman","year":"2008","journal-title":"J Hosp Med"},{"key":"R12-20230721","article-title":"Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.","author":"Zou","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-20230721","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1097\/00000539-199912000-00011","article-title":"The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists.","volume":"89","author":"Brabant","year":"1999","journal-title":"Anesth Analg"},{"key":"R14-20230721","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1213\/01.ANE.0000146521.68059.A1","article-title":"Angiotensin system inhibitors in a general surgical population.","volume":"100","author":"Comfere","year":"2005","journal-title":"Anesth Analg"},{"key":"R15-20230721","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/bja\/83.5.715","article-title":"Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements.","volume":"83","author":"Pigott","year":"1999","journal-title":"Br J Anaesth"},{"key":"R16-20230721","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"R17-20230721","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R20-20230721","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0034-7094(09)70095-9","article-title":"Influence of angiotensin-converting enzyme inhibitors on hypotension after anesthetic induction: is the preoperative discontinuation of this drug necessary?","volume":"59","author":"da Costa","year":"2009","journal-title":"Rev Bras Anestesiol"},{"key":"R21-20230721","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jocn.2013.10.019","article-title":"Renin-angiotensin system inhibitors and troponin elevation in spinal surgery.","volume":"21","author":"McClendon","year":"2014","journal-title":"J Clin Neurosci"},{"key":"R22-20230721","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.jvca.2007.12.020","article-title":"Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.","volume":"22","author":"Kheterpal","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R23-20230721","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/00000542-200306000-00007","article-title":"Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors.","volume":"98","author":"Boccara","year":"2003","journal-title":"Anesthesiology"},{"key":"R24-20230721","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000542-200501000-00006","article-title":"Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics.","volume":"102","author":"Morelli","year":"2005","journal-title":"Anesthesiology"},{"key":"R25-20230721","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1213\/00000539-199802000-00007","article-title":"Treating anesthesia-induced hypotension by angiotensin II in patients chronically treated with angiotensin-converting enzyme inhibitors.","volume":"86","author":"Eyraud","year":"1998","journal-title":"Anesth Analg"},{"key":"R26-20230721","first-page":"670","article-title":"Severe hypotension after induction of general anesthesia in a patient receiving an angiotensin II receptor antagonist and an alpha-blocker.","volume":"54","author":"Shibata","year":"2005","journal-title":"Masui"},{"key":"R27-20230721","doi-asserted-by":"crossref","first-page":"649","DOI":"10.4103\/1119-3077.141440","article-title":"\u201cQuadruple whammy\u201d\u2014a preventable newly described syndrome of post-operative AKI in CKD II and CKD III patients on combination \u201cTriple whammy\u201d medications: a Mayo Clinic Health System, Eau Claire, Wisconsin experience.","volume":"17","author":"Onuigbo","year":"2014","journal-title":"Niger J Clin Pract"},{"key":"R28-20230721","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1213\/00000539-199910000-00012","article-title":"Refractory hypotension after induction of anesthesia in a patient chronically treated with angiotensin receptor antagonists.","volume":"89","author":"Brabant","year":"1999","journal-title":"Anesth Analg"},{"key":"R29-20230721","first-page":"16","article-title":"The importance of interrupting angiotensin converting enzyme inhibitor treatment before spinal anaesthesia\u2014a controlled case report.","volume":"29","author":"Cozanitis","year":"2004","journal-title":"Anaesthesiol Reanim"},{"key":"R30-20230721","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0310057X1604400305","article-title":"Perioperative management of patients treated with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a quality improvement audit.","volume":"44","author":"Vijay","year":"2016","journal-title":"Anaesth Intensive Care"},{"key":"R31-20230721","first-page":"A4543","article-title":"No consensus on withholding angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before spinal anaesthesia.","volume":"59","author":"B\u00f8gebjerg","year":"2012","journal-title":"Dan Med J"},{"key":"R32-20230721","first-page":"A1200","article-title":"Should ambulatory & same day admission PTS discontinue angiotensin system inhibitors preoperatively?","volume":"109","author":"Griffin","year":"2008","journal-title":"Anesthesiology"},{"key":"R33-20230721","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jhm.2182","article-title":"Thirty-day mortality risk associated with the postoperative nonresumption of angiotensin-converting enzyme inhibitors: a retrospective study of the Veterans Affairs Healthcare System.","volume":"9","author":"Mudumbai","year":"2014","journal-title":"J Hosp Med"},{"key":"R34-20230721","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/ALN.0000000000000739","article-title":"Association between withholding angiotensin receptor blockers in the early postoperative period and 30-day mortality: a cohort study of the Veterans Affairs Healthcare System.","volume":"123","author":"Lee","year":"2015","journal-title":"Anesthesiology"},{"key":"R35-20230721","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jash.2014.05.017","article-title":"Hemodynamic effects of angiotensin inhibitors in elderly hypertensives undergoing total knee arthroplasty under regional anesthesia.","volume":"8","author":"Calloway","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"R36-20230721","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0259-1162.128903","article-title":"Effect of pre-operative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists on intra-operative arterial pressures after induction of general anesthesia.","volume":"8","author":"Rajgopal","year":"2014","journal-title":"Anesth Essays Res"},{"key":"R37-20230721","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00101-007-1177-x","article-title":"[Preoperative administration of angiotensin-converting enzyme inhibitors].","volume":"56","author":"Schirmer","year":"2007","journal-title":"Anaesthesist"},{"key":"R38-20230721","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s12630-011-9575-6","article-title":"More hypotension in patients taking antihypertensives preoperatively during shoulder surgery in the beach chair position.","volume":"58","author":"Trentman","year":"2011","journal-title":"Can J Anaesth"},{"key":"R39-20230721","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1213\/ANE.0000000000000076","article-title":"The risk of hypertension after preoperative discontinuation of angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists in ambulatory and same-day admission patients.","volume":"118","author":"Twersky","year":"2014","journal-title":"Anesth Analg"},{"key":"R40-20230721","doi-asserted-by":"crossref","first-page":"III36","DOI":"10.1161\/01.HYP.5.5_Pt_2.III36","article-title":"Renin system activity as a determinant of response to treatment in hypertension and heart failure.","volume":"5","author":"Cody","year":"1983","journal-title":"Hypertension"},{"key":"R41-20230721","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.","volume":"5","author":"Carson","year":"1999","journal-title":"J Card Fail"},{"key":"R42-20230721","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/01.HYP.25.1.88","article-title":"Racial differences in epinephrine and beta 2-adrenergic receptors.","volume":"25","author":"Mills","year":"1995","journal-title":"Hypertension"},{"key":"R43-20230721","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ajh\/6.7.630","article-title":"Responsiveness to alpha- and beta-adrenergic receptor agonists. Effects of race in borderline hypertensive compared to normotensive men.","volume":"6","author":"Sherwood","year":"1993","journal-title":"Am J Hypertens"},{"key":"R44-20230721","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/jama.280.13.1168","article-title":"Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.","volume":"280","author":"Preston","year":"1998","journal-title":"JAMA"},{"key":"R45-20230721","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM200105033441802","article-title":"Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction.","volume":"344","author":"Exner","year":"2001","journal-title":"N Engl J Med"},{"key":"R46-20230721","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/ALN.0b013e3182a10e26","article-title":"Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension.","volume":"119","author":"Walsh","year":"2013","journal-title":"Anesthesiology"},{"key":"R47-20230721","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2012.5502","article-title":"Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.","volume":"307","author":"Devereaux","year":"2012","journal-title":"JAMA"},{"key":"R48-20230721","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/ALN.0000000000000113","article-title":"Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.","volume":"120","author":"Botto","year":"2014","journal-title":"Anesthesiology"},{"key":"R49-20230721","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1213\/ANE.0b013e318241f6af","article-title":"Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery.","volume":"114","author":"Turan","year":"2012","journal-title":"Anesth Analg"},{"key":"R50-20230721","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12630-010-9330-4","article-title":"Renin-angiotensin blockade is associated with increased mortality after vascular surgery.","volume":"57","author":"Railton","year":"2010","journal-title":"Can J Anaesth"},{"key":"R51-20230721","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1213\/ANE.0b013e31824e2d20","article-title":"Acute kidney injury after lung resection surgery: incidence and perioperative risk factors.","volume":"114","author":"Ishikawa","year":"2012","journal-title":"Anesth Analg"},{"key":"R52-20230721","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jhm.2155","article-title":"Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery.","volume":"9","author":"Nielson","year":"2014","journal-title":"J Hosp Med"},{"key":"R53-20230721","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/bja\/aex056","article-title":"Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery.","volume":"119","author":"Venkatesan","year":"2017","journal-title":"Br J Anaesth"},{"key":"R54-20230721","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/01.anes.0000271863.20091.60","article-title":"The impact of lack of standardized definitions on the specialty.","volume":"107","author":"Warner","year":"2007","journal-title":"Anesthesiology"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201809000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:24:26Z","timestamp":1786112666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201809000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000002837","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}